LOGO.jpg
GD Culture Group Limited Announces Registered Direct Offering
March 22, 2024 20:20 ET | GD Culture Group Limited
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC), a holding company currently conducting business through its operating subsidiary, AI...
LOGO.png
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
February 21, 2024 16:05 ET | NEXGEL, INC.
LANGHORNE, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle,...
LOGO.jpg
Yoshitsu Co., Ltd. Announces Pricing of $4.0 Million Registered Direct Offering and Private Placement
January 26, 2024 09:00 ET | Yoshitsu Co., Ltd
Tokyo, Japan, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products,...
univest-logo.png
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client GD Culture Group Limited (NASDAQ: GDC)
November 03, 2023 16:30 ET | Univest Securities, LLC
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York,...
worksport-nasdaq-wksp.png
Worksport Announces Pricing of Approximately $4.7 Million Registered Direct Offering & Concurrent Private Placement
October 31, 2023 08:12 ET | Worksport Ltd
West Seneca, New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq: WKSP; WKSPW) (“Worksport” or the “Company”) is pleased to announce today that it has entered into a securities...
scinai logo whitespace border (002).jpg
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
September 19, 2023 16:05 ET | Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing...
scinai logo whitespace border (002).jpg
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
September 15, 2023 09:01 ET | Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 15, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Announces Closing of $2 Million Registered Direct Offering Priced At Market Under Nasdaq Rules
September 11, 2023 16:01 ET | Palisade Bio, Inc.
Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Announces $2 Million Registered Direct Offering of Common Stock Priced At Market Under Nasdaq Rules
September 07, 2023 08:30 ET | Palisade Bio, Inc.
Carlsbad, CA, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is...
abvc-logo-nasdaq-440x386 (1).png
ABVC BioPharma Announces Closing on $1.75 Million Registered Direct Offering
July 31, 2023 09:30 ET | ABVC BioPharma, Inc.
FREMONT, CA, July 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...